Cornileus Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2001.
2001 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Cornileus Pharmaceuticals Private Limited

Cornileus Pharmaceuticals Private Limited, a active private limited company, was established on 28 December 2001 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2001PTC038288. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.59 Cr.

It upholds a compliant status. Employing 124 professional, Its leadership includes Jagarlamudi Suresh Babu (Director), Kiran Kumar Nalamothu (Managing Director), Venkat Samraj Jagarlamudi (Director). Past directors included Subba Rao Nallamothu, Jagarlamudi Suresh Babu, Kiran Kumar Nalamothu. It holds ₹17.00 Cr open charges and ₹66.56 Cr settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No:1-98/V/103,Flat No.103,Plot No.17&18,Vishnu Avenues, Krithika Layout, Madhapur,, Hyderabad, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2001PTC038288

  • Registration Number

    038288

  • Incorporation Date

    28 December 2001

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.59 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.59 Cr
  • Company Age 24 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 17.00 Cr
  • Satisfied Charges ₹ 66.56 Cr
  • Revenue Growth **** 14.70%
  • Profit Growth **** -11.13%
  • Ebitda **** -20.89%
  • Net Worth -24.56%
  • Total Assets -11.11%
Company report

Cornileus Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cornileus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Cornileus Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Jagarlamudi Suresh Babu Director 28 Dec 2020 Current
Kiran Kumar Nalamothu Managing Director 05 Nov 2018 Current
Venkat Samraj Jagarlamudi Director 28 Dec 2020 Current
Vijayalakshmi Nalamothu Director 17 Oct 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 17 Feb 2013 Past
Pramod Abcsdd Additional Director 25 Oct 2021 Past
Pramod Abcsdd Managing Director 17 Oct 2017 Past
Pramod Abcsdd Additional Director 18 May 2011 Past
Pramod Abcsdd Director 28 Dec 2020 Past
Pramod Abcsdd Additional Director 27 Sep 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cornileus Pharmaceuticals.

Cornileus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.7% increase. The company also saw a substantial fall in profitability, with a 11.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.56%.

Cornileus Pharmaceuticals revenue growth over time
Cornileus Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 14.70%
*******
*******
*******
*******
Revenue from Operations
*******
 12.37%
*******
*******
*******
*******
Total Assets
*******
 -11.11%
*******
*******
*******
*******
Profit or Loss
*******
 -11.13%
*******
*******
*******
*******
Net Worth
*******
 -24.56%
*******
*******
*******
*******
EBITDA
*******
 -20.89%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cornileus Pharmaceuticals?

In 2022, Cornileus Pharmaceuticals had a promoter holding of 39.31% and a public holding of 60.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹170,000,000.00

Satisfied Charges

₹665,600,000.00

Charges Breakdown by Lending Institutions
  • Others : 17.00 Cr
Latest Charge Details
Date Lender Amount Status
06 May 2024 Others ₹7.50 Cr Open
01 Feb 2019 Others ₹9.50 Cr Open
07 Feb 2020 State Bank Of India ₹31.71 Cr Satisfied
25 Sep 2013 Andhra Bank ₹1.00 Cr Satisfied
23 Aug 2011 Andhra Bank ₹3.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cornileus Pharmaceuticals?

Cornileus Pharmaceuticals has a workforce of 124 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cornileus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cornileus Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cornileus Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 07 Feb 2020 via Charge ID 100326337 with State Bank Of India was fully satisfied on 20 Jun 2025. was completed.

  • Annual General Meeting

    Cornileus Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100924158 was registered on 06 May 2024. was recorded as a recent event.

  • Balance Sheet

    Cornileus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 9.50 Cr registered on 01 Feb 2019 with Charge ID 100238506 was modified on 20 Sep 2022. was recorded as a recent event.

  • Director Appointment

    Jagarlamudi Suresh Babu was appointed as a Director was appointed as a Director on 28 Dec 2020 & has been associated with this company since 5 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cornileus Pharmaceuticals Private Limited?

The CIN of Cornileus Pharmaceuticals Private Limited is U24239TG2001PTC038288.

Where is Cornileus Pharmaceuticals Private Limited headquartered?

Cornileus Pharmaceuticals Private Limited is headquartered at H.No:1-98/V/103,Flat No.103,Plot No.17&18,Vishnu Avenues, Krithika Layout, Madhapur,, Hyderabad, Telangana, 500081.

When was Cornileus Pharmaceuticals Private Limited incorporated?

Cornileus Pharmaceuticals Private Limited was incorporated on 28 December 2001.

Who are the current directors of Cornileus Pharmaceuticals Private Limited?

The current directors of Cornileus Pharmaceuticals Private Limited are

What is the primary industry of Cornileus Pharmaceuticals Private Limited?

The primary industry of Cornileus Pharmaceuticals Private Limited is Manufacturing.

Is Cornileus Pharmaceuticals Private Limited a listed company?

Cornileus Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Cornileus Pharmaceuticals Private Limited?

The authorized capital of Cornileus Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.59 Cr.

What is the compliance status of Cornileus Pharmaceuticals Private Limited?

The compliance status of Cornileus Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available